Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control

The LMNX genotyping kit HPV GP (LMNX) is based on the clinically validated GP5+/6+ PCR, with a genotyping readout as an alternative for the more established enzyme immunoassay (EIA) detection of 14 targeted high-risk human papillomavirus (HPV) types. LMNX is additionally provided with an internal co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Microbiol
Main Authors: Geraets, D. T., Cuschieri, K., de Koning, M. N. C., van Doorn, L. J., Snijders, P. J. F., Meijer, C. J. L. M., Quint, W. G. V., Arbyn, M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Virology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4313237/
https://ncbi.nlm.nih.gov/pubmed/25210073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01962-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados